Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 1, 2014, Pages

  Martín, Paloma ^a,b,c   Mora, Inés ^b,c   Cortes, M Alicia ^a,b,c   Calleros, Laura ^a,b,c   García Jerez, Andrea ^a,b,c   Ortiz, Alberto ^b,e   Rodríguez Puyol, Manuel ^a,b,c   Rodríguez Puyol, Diego ^a,b,c,d   Olmos, Gemma ^a,b,c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto Reina Sofia de Investigaciones Nefrologicas   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Fibrosis; Kidney; Protein kinase G I; Ras protein; Tumor necrosis factor like weak inducer of apoptosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 8 BROMO CYCLIC GMP; COLLAGEN TYPE 1; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER APOPTOSIS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; KIDNEY CELL; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MESANGIUM CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

FIBROSIS; KIDNEY; PROTEIN KINASE G-I; RAS PROTEIN; TRANSFORMING GROWTH FACTOR-Β1; TUMOR NECROSIS FACTOR-LIKE WEAK INDUCER OF APOPTOSIS;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBROSIS; FLAVONOIDS; GENES, RAS; KIDNEY; MESANGIAL CELLS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 84903575719     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00398.2013     Document Type: Article

References (61)

1. Browner NC, Sellak H, Lincoln TM. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells. Am J Physiol Cell Physiol 287: C88-C96, 2004.
2. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 40: 1-16, 2007.
3. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. Proinflammatory effects of Tweak/Fn14 interactions in glomerular mesangial cells. J Immunol 176: 1889-1898, 2006.
4. Chamorro-Jorganes A, Calleros L, Griera M, Saura M, Luengo A, Rodriguez-Puyol D, Rodriguez-Puyol M. Fibronectin upregulates cGMP-dependent protein kinase type Iβ through C/EBP transcription factor activation in contractile cells. Am J Physiol Cell Physiol 300: C683-C691, 2011.
5. Chamorro-Jorganes A, Grande MT, Herranz B, Jerkic M, Griera M, Gonzalez-Nuñez M, Santos E, Rodriguez-Puyol D, Lopez-Novoa JM, Rodriguez-Puyol M. Targeted genomic disruption of H-Ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism. Hypertension 56: 484-489, 2010.
6. Chen HN, Wang DJ, Ren MY, Wang QL, Sui SJ. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-κB pathway. Mol Biol Rep 39: 8231-841, 2012.
7. Chen L, Daum G, Chitaley K, Coats SA, Bowen-Pope DF, Eigenthaler M, Thumati NR, Walter U, Clowes AW. Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 8: 1403-1408, 2004.
8. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia L, Browning JL. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272: 32401-32410, 1997.
9. Esteban LM, Vicario-Abejón C, Fernández-Salguero P, Fernández-Medarde A, Swaminathan N, Yienger K, López E, Malumbres M, McKay R, Ward JM, Pellicer A, Santos E. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444-1452, 2001.
10. Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, Banas B, Saleem MA, Mathieson PW, Berman JW, Michaelson JS, Putterman C. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 46: 24-35, 2009.
11. Gao Y, Dhanakoti S, Trevino EM, Wang X, Sander FC, Portugal AD, Rai JU. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol Lung Cell Mol Physiol 286: L786-L792, 2004.
12. González-Ramos M, Calleros L, López-Ongil S, Raoch V, Griera M, Rodríguez-Puyol M, Frutos S, Rodríguez-Puyol D. HSP70 increases extracellular matrix production by human vascular smooth muscle through TGF-β1 up-regulation. Int J Biochem Cell Biol 45: 232-242, 2013.
13. González-Ramos M, Mora I, Frutos S, Garesse R, Rodríguez-Puyol M, Olmos G, Rodríguez-Puyol D. Intracellular redox equilibrium is essential for the constitutive expression of AP-1 dependent genes in resting cells: studies on TGF-β1 regulation. Int J Biochem Cell Biol 44: 963-971, 2012.
14. Grande MT, López-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 5: 319-328, 2009.
15. Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y. Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79: 179-188, 2011.
16. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Díez-Marqués L, Ortega-Velázquez R, Chen S, Rodríguez-Puyol M, Ziyadeh FN, Rodríguez-Puyol D. Hydrogen peroxide increases extracelular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87-95, 2001.
17. Kim SI, Kwak JH, Zachariah M, He Y, Wang L, Choi ME. TGF-β-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-β1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol Renal Physiol 292: F1471-F1478, 2007.
18. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74: 991-1003, 1996.
19. Kumar M, Makonchuk DY, Li H, Mittal A, Kumar A. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) activates proinflammatory signalling pathways and gene expression through the activation of TGF-beta activated kinase 1. J Immunol 182: 2439-2448, 2009.
20. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 7: 328-338, 1993.
21. Lincoln TM, Wu X, Sellak H, Dey NB, Choi CS. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 11: 356-367, 2006.
22. López-Hernández FJ, López-Novoa JM. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347: 141-154, 2012.
23. López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, López-Fernández FJ. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectivas. Pharmacol Ther 128: 61-81, 2010.
24. López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, López-Hernández FJ. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med 9: 13, 2011.
25. Macara IG, Lounsbury KM, Richards SA, McKiernan C, Bar-Sagi D. The Ras superfamily of GTPases. FASEB J 10: 625-630, 1996.
26. Martínez-Salgado C, Fuentes-Calvo I, García-Cenador B, Santos E, Lopez-Novoa JM. Involvement of H and N-Ras isoforms in transforming growth factor-β1-induced proliferation and in collagen and fibronectin synthesis. Exp Cell Res 312: 2093-2106, 2006.
27. Martínez-Salgado C, Rodríguez-Peña AB, López-Novoa JM. Involvement of small Ras GTPases and their effectors in chronic renal disease. Cell Mol Life Sci 65: 477-492, 2008.
28. McKay MM, Morrison DK. Integrating signals from RTKs to ERK/ MAPK. Oncogene 26: 3113-3121, 2007.
29. Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, Li H, Makonchuk DY, Glass DJ, Kumar A. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol 188: 833-849, 2010.
30. Morimoto Y, Gai Tanishima H Z, Kawakatsu M, Itoh S, Hatamura I, Muragaki Y. TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp Mol Pathol 85: 207-213, 2008.
31. Novoyatleva T, Schymura Y, Janssen W, Strobl F, Swiercz JM, Patra C, Posern G, Wietelmann A, Zheng TS, Schermuly RT, Engel FB. Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction. Cytokine 108: 325, 2013.
32. Orstavik S, Natarajan V, Tasken K, Jahnsen T, Sandberg M. Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics 42: 311-318, 1997.
33. Ortega-Velázquez R, Díez-Marqués ML, Ruiz-Torres MP, González-Rubio M, Rodríguez-Puyol M, Rodríguez Puyol D. Arg-Gly-Asp-Ser (RGDS) peptide stimulates transforming growth factor beta1 transcription and secretion through integrin activation. FASEB J 17: 1529-1531, 2003.
34. Ortega-Velazquez R, González-Rubio M, Ruiz-Torres MP, Diez-Marques ML, Iglesias MC, Rodríguez-Puyol M, Rodríguez-Puyol D. Collagen I upregulates extracellular matrix gene expression and secretion of TGF-β1 by cultured human mesangial cells. Am J Physiol Cell Physiol 286: C1335-C1343, 2004.
35. Panguluri SK, Bhatnagar S, Kumar A, McCarthy JJ, Srivastava AK, Cooper NG, Lundy RF, Kumar A. Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PLOS ONE 5: e8760, 2010.
36. Park BJ, Park JI, Byun DS, Park JH, Chi SG. Mitogenic conversion of transforming growth factorbeta1effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signalling pathway in human prostate cancer. Cancer Res 60: 3031-3038, 2000.
37. Pilz BR, Broderick KE. Role of cyclic GMP in gene regulation. Front Biosci 10: 1239-1268, 2005.
38. Rooij J, Bos JL. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14: 623-625, 1997.
39. Ruiz-Torres MP, Pérez-Rivero G, Díez-Marqués ML, Griera M, Ortega R, Rodriguez-Puyol M, Rodríguez-Puyol D. Role of activator protein-1 on the effect of arginine-glycine-aspartic acid containing peptides on transforming growth factor-beta1 promoter activity. Int J Biochem Cell Biol 39: 133-145, 2007.
40. Sanchez-Niño MD, Benito-Martin A, Goncalves S, Sanz AB, Ucero AC, Izquierdo MC, Ramos AM, Berzal S, Selgas R, Ruiz-Ortega MA, Egido J, Ortiz A. TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm; doi:10.1155/2010/182958.
41. Santibanez FJ, Guerrero J, Quintanilla M, Fabra A, Martinez J. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 296: 267-273, 2002.
42. Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM, Winkles JA, Kreztler M, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19: 695-703, 2008.
43. Sanz AB, Sanchez-Nino MD, Izquierdo MC, Jakubowski A, Justo A, Blanco-Colio LM, Ruiz-Ortega M, Selgas R, Egido Ortiz A J. TWEAK activates the non-canonical NF-B pathway in murine renal tubular cells: modulation of CCL21. PLOS ONE 5: e8955, 2010.
44. Sanz AB, Santamaria B, Ruiz-Ortega M, EgIdo J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 19: 1634-1642, 2008.
45. Saura M, Zaragoza C, Herranz B, Griera M, Diez-Marqués L, Rodriguez-Puyol D, Rodriguez-Puyol M. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Circ Res 97: 1115-1123, 2005.
46. Schnaper HW, Jandeska S, Runyan CE, Hubchak SC, Basu RK, Curley JF, Smith RD, Hayashida T. TGF-β signal transduction in chronic kidney disease. Front Biosci 14: 2448-2465, 2009.
47. Shimojo T, Hiroe M, Ishiyama S, Ito H, Nishikawa T, Marumo F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMPdependent pathway. Exp Cell Res 247: 38-47, 1999.
48. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. Analysis and regulation of vasodilator stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273: 20029-20035, 1998.
49. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286: 1583-1587, 1999.
50. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001.
51. Torrecillas G, Díez-Marqués ML, García-Escribano C, Bosch RJ, Rodríguez-Puyol D, Rodríguez-Puyol M. Mechanisms of cGMP-dependent mesangial-cell relaxation: a role for myosin light-chain phosphatase activation. Biochem J 346: 217-222, 2000.
52. Ucero AC, Benito-Martin A, Fuentes-Calvo I, Santamaria B, Blanco J, Lopez-Novoa JM, Ruiz-Ortega M, Egido J, Burkly LC, Martinez-Salgado C, Ortiz A. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta 1832: 1744-1755, 2013.
53. Wang S, Lincoln TM, Murphy-Ullrich JE. Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-β activity in vascular smooth muscle cells. Am J Physiol Cell Physiol 298: C1188-C1197, 2010.
54. Wang S, Shiva S, Poczatek MH, Darley-Usmar V, Murphy-Ullrich JE. Nitric oxide and cGMP-dependent protein kinase regulation of glucose mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J Biol Chem 277: 9880-9888, 2002.
55. Wang S, Skorczewski J, Feng X, Mei L, Murphy-Ullrich JE. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-β activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279: 34311-34322, 2004.
56. Wang S, Wu X, Lincoln TM, Murphy-Ullrich JE. Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-β activity. Diabetes 522: 144-2150, 2003.
57. Wang Y, Kramer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Harm P. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition. Am J Physiol Renal Physiol 290: F167-F176, 2006.
58. Weston BS, Wahab NA, Mason RM. CTGF-mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells. J Am Soc Nephrol 14: 601-610, 2003.
59. Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7: 411-425, 2008.
60. Wolf G. Link between angiotensin II and TGF-beta in the kidney. Miner Electrolyte Metab 24: 174-180, 1998.
61. Ying WZ, Sanders PW. The interrelationship between TGF-β1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol 285: F902-F908, 2003.